Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning
First Claim
Patent Images
1. A non-invasive monitoring method, comprising:
- non-invasively obtaining, via a non-invasive monitoring system configured to removably attach to an outer biological surface of a biological subject under test and operable to deliver an ex vivo generated interrogation stimulus to a region including a body fluid vessel of the biological subject, a first spectral information associated with an embolus, an occlusion, or a blood clot formation within the body fluid vessel of the biological subject while varying at least one of a wavelength or a frequency associated with the ex vivo generated interrogation stimulus;
partitioning the first spectral information into one or more information subsets according to one or more spectral learning protocols;
comparing at least one parameter associated with a second spectral information from the biological subject to at least one parameter associated with at least one of the one or more information subsets; and
generating a response indicative of at least one physical parameter associated with the embolus, the occlusion, or the blood clot formation within the body fluid vessel based on the comparison of the at least one parameter associated with the second spectral information to the at least one parameter associated with at least one of the one or more information subsets.
2 Assignments
0 Petitions
Accused Products
Abstract
Systems, devices, and methods are described for detecting an embolus, thrombus, or a deep vein thrombus in a biological subject.
-
Citations
19 Claims
-
1. A non-invasive monitoring method, comprising:
-
non-invasively obtaining, via a non-invasive monitoring system configured to removably attach to an outer biological surface of a biological subject under test and operable to deliver an ex vivo generated interrogation stimulus to a region including a body fluid vessel of the biological subject, a first spectral information associated with an embolus, an occlusion, or a blood clot formation within the body fluid vessel of the biological subject while varying at least one of a wavelength or a frequency associated with the ex vivo generated interrogation stimulus; partitioning the first spectral information into one or more information subsets according to one or more spectral learning protocols; comparing at least one parameter associated with a second spectral information from the biological subject to at least one parameter associated with at least one of the one or more information subsets; and generating a response indicative of at least one physical parameter associated with the embolus, the occlusion, or the blood clot formation within the body fluid vessel based on the comparison of the at least one parameter associated with the second spectral information to the at least one parameter associated with at least one of the one or more information subsets. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A non-invasive occlusion monitoring method, comprising:
-
obtaining spectral information from a biological subject, via a non-invasive monitoring system configured to removably attach to an outer biological surface of the biological subject under test and operable to deliver an ex vivo generated interrogation stimulus to a region including a body fluid vessel of the biological subject, while varying at least one of a wavelength or a frequency associated with an interrogation optical excitation energy source; comparing at least one parameter associated with the obtained spectral information to one or more information subsets derived from partitioning spectral information associated with the biological subject; generating a response indicative of at least one physical parameter associated with an embolus, an occlusion, or a blood clot formation within a body fluid vessel based on the comparison of the at least one parameter associated with the obtained spectral information to the one or more information subsets derived from partitioning spectral information associated with the biological subject, and performing a real-time update of at least one parameter associated with a spectral blood clotting model associated with the biological subject under test. - View Dependent Claims (15, 16, 17, 18, 19)
-
Specification